Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes

OBJECTIVE: Posaconazole prophylaxis during induction chemotherapy for acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS) has been shown to significantly decrease the incidence of invasive fungal disease (IFD) and increase overall survival in a trial setting, but only small real‐life s...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahlén, Torsten, Kalin, Mats, Cederlund, Kerstin, Nordlander, Anna, Björkholm, Magnus, Ljungman, Per, Blennow, Ola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744717/
https://www.ncbi.nlm.nih.gov/pubmed/25880378
http://dx.doi.org/10.1111/ejh.12565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744717/
https://www.ncbi.nlm.nih.gov/pubmed/25880378
http://dx.doi.org/10.1111/ejh.12565

Ejemplares similares